Azithromycin for the Prevention of COPD Exacerbations: The Good, Bad, and Ugly
- 1 December 2015
- journal article
- review article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 128 (12), 1362.e1-1362.e6
- https://doi.org/10.1016/j.amjmed.2015.07.032
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care populationRespiratory Medicine, 2014
- High-risk patients following hospitalisation for an acute exacerbation of COPDEuropean Respiratory Journal, 2013
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2010
- Inhaled Corticosteroids vs Placebo for Preventing COPD ExacerbationsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsThe Lancet, 2009
- Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax, 2005
- Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax, 2004
- Measurement of Short-term Changes in Dyspnea and Disease-Specific Quality of Life Following an Acute COPD ExacerbationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987